State-level prevalence of adult obesity and severe obesity
Baseline kidney function testing before initiating either substance, with periodic monitoring based on individual risk factors, represents prudent clinical practice, particularly in patients with diabetes or other kidney disease risk factors
Vikrant Shrotriya, Corporate VP and Managing Director, Novo Nordisk India, as he shares sharp insights on how this #formulation race is reshaping the rapidly evolving Indian GLP-1 market at #PCG2025 in session on, "Rapid Rise of GLP-1 Drugs: Weight Loss, Wellness & Beyond" moderated by the sensational Mr
Tirzepatide, a novel dual GIP and GLP-1 receptor agonist, has demonstrated significant efficacy in reducing sleep apnea severity in adults with OSA and obesity
O.BandmannO
Prior to use, patients need to resuspend the PLGA microparticles containing 2 mg exenatide in 0.65 ml phosphate buffer, which also contains sodium chloride (tonicity adjuster), carboxymethylcellulose sodium (suspending agent) and polysorbate 20 (surfactant) (Table 2) [21]
